|  |



Health CEO demonstrates getting injectable HIV preventive drug Yeztugo

The Food and Drug Administration approved the twice-a-year HIV preventive drug lenacapavir. Gilead will market the drug under the brand name ...


View article...


Top stories of the last 30 days